N-[1-(1H-1,3-benzodiazol-2-yl)-3-(methylsulfanyl)propyl]-3-methyl-1-benzofuran-2-carboxamide
95%
- Product Code: 245664
CAS:
851453-95-7
| Molecular Weight: | 379.48 g./mol | Molecular Formula: | C₂₁H₂₁N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 666.6±55.0 °C(Predicted) | |
| Density: | 1.292±0.06 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound plays a key role in modulating biological pathways related to inflammation, pain, and cardiovascular function. Its primary application lies in the development of therapies for inflammatory diseases, neuropathic pain, and hypertension due to its ability to stabilize endogenous epoxy fatty acids, which have anti-inflammatory and vasodilatory effects. It is also employed as a reference compound in enzyme activity assays and metabolic studies involving sEH inhibition. Due to its favorable pharmacokinetic profile in preclinical models, it serves as a lead structure in medicinal chemistry for optimizing new drug candidates targeting chronic inflammatory and metabolic disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | $94.63 |
+
-
|
| 25mg | 10-20 days | $1,520.20 |
+
-
|
| 5mg | 10-20 days | $379.83 |
+
-
|
N-[1-(1H-1,3-benzodiazol-2-yl)-3-(methylsulfanyl)propyl]-3-methyl-1-benzofuran-2-carboxamide
Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound plays a key role in modulating biological pathways related to inflammation, pain, and cardiovascular function. Its primary application lies in the development of therapies for inflammatory diseases, neuropathic pain, and hypertension due to its ability to stabilize endogenous epoxy fatty acids, which have anti-inflammatory and vasodilatory effects. It is also employed as a reference compound in enzyme activity assays and metabolic studies involving sEH inhibition. Due to its favorable pharmacokinetic profile in preclinical models, it serves as a lead structure in medicinal chemistry for optimizing new drug candidates targeting chronic inflammatory and metabolic disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :